Discover the power of real-time signals plus AI
Every funding round, exec hire, M&A move, contract, and sentiment shift on Aidoc — with verified, ICP-scored contact reveals (email + mobile) on demand.
Trusted by founders, sales teams, recruiters, and investors at firms like BlackRock, Oracle, Kleiner Perkins, and HubSpot.
Aidoc has raised $150 million in Series E funding led by Goldman Sachs to enhance its clinical AI capabilities. The investment aims to improve diagnostic efficiency across health systems.
Amount Raised
$150 Million
Round Type
series e
Investors
Description
Aidoc, a leader in clinical AI, raised $150 million in Series E funding led by Goldman Sachs Alternatives, with participation from General Catalyst, SoftBank Investment Advisors, and NVentures. The funding will help scale Aidoc's enterprise AI platform to combat diagnostic errors. This round brings total funding to over $500 million. The investment underscores the growing demand for advanced clinical AI in healthcare.
Related People
Funding Insights
Based on industry dataWatching Aidoc? See every signal — funding, hires, M&A, contracts, sentiment.
See plans